print, photography, gelatin-silver-print
portrait
photography
gelatin-silver-print
academic-art
Dimensions height 149 mm, width 103 mm
Curator: Good morning. Editor: This is a gelatin silver print, taken before 1881. It’s titled "Patiënt lijdend aan de huidziekte ‘chromophytosis’," or "Patient suffering from the skin disease 'chromophytosis.'" It’s… well, clinical, stark even. It makes me a bit uneasy to see the subject displayed like this. How do you interpret this work? Curator: I see this not just as a clinical study, but as a visual document reflecting the power dynamics inherent in the medical gaze of the 19th century. Photography was then a relatively new tool, offering a seemingly objective means of recording the body, particularly marginalized or pathologized bodies. It's easy to forget the individuals behind these images, stripped of their agency. What impact does it have to learn that we don't know the name of the depicted person? Editor: It emphasizes the sense of objectification, I suppose. Without a name, he's solely defined by his condition, divorced from his humanity. Do you think there's a risk of perpetuating that objectification by displaying the work today? Curator: Absolutely. But displaying it thoughtfully can be an intervention. We must contextualize these images, acknowledging the harm they inflicted, and encouraging viewers to critically examine the power structures at play. We might consider how photography contributed to racial and gendered biases within medicine, or to the stigmatization of illness. Can you see that link? Editor: Yes, it’s much clearer now. It is a product of a specific historical moment. Showing it prompts necessary questions. Curator: Precisely. By confronting these difficult images, we can foster a more ethical and equitable approach to healthcare and visual representation. Editor: Thank you. It really broadens the view to place it into this historical framework. Curator: You're most welcome. Considering social contexts illuminates how far we've come—and the challenges that remain.
Comments
No comments
Be the first to comment and join the conversation on the ultimate creative platform.